Medical News

RSS

NanoString Technologies to investigate molecular networks with the Broad Institute of MIT and Harvard

NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that it is collaborating with the Broad Institute of MIT and Harvard to investigate molecular networks involved in immune response and other important biological processes.

From NanoString Technologies 19 Nov 2009

Global 'phase down' of dental mercury use finds support

Hailed as "a breakthrough" by Green Groups, an agreement in concept was reached yesterday by a World Health Organization (W.H.O.)-convened international expert group, supporting the "phase down" of dental mercury use worldwide. However, the groups note that there is still much work to be done in deciding how and when a global dental amalgam phase down will occur.

19 Nov 2009

Molina Healthcare's Medicaid plans included in 'America’s Best Health Insurance Plans'

Molina Healthcare, Inc., today announced that U.S. News and World Report has ranked all of Molina’s eligible subsidiary Medicaid health plans in California, Michigan, New Mexico, Ohio, Utah and Washington among “America’s Best Health Insurance Plans” in the magazine’s annual report measuring the quality and performance of the nation’s Medicaid health plans.

19 Nov 2009

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.

19 Nov 2009

New online tool launched to encourage donations and fight global hunger

Mercy Corps is challenging Americans to put the "giving" back in Thanksgiving by matching the amount they spend on a meal this Thanksgiving Day with a donation that fights global hunger.

19 Nov 2009

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.

19 Nov 2009

NeuroRehabilitation: A one-stop resource for persons with neurodisabilities

IOS Press announces the November 2009 publication of a special issue of NeuroRehabilitation: An International Journal devoted to residential design for persons with neurodisability.

19 Nov 2009

New study sheds light on potassium pore dynamics and serves as an important foundation for research

The December 2009 issue of the Journal of General Physiology (JGP) contains a paper by Christopher Ahern (The University of British Columbia, Vancouver) and colleagues that explores pore mutation effects in Shaker and other K+ channels using in vivo nonsense suppression technology. The study will be published online November 16 (www.jgp.org).

19 Nov 2009

Breastcancer.org opposes proposed new guidelines for mammograms

"The recommendation to change breast screening is a huge step backwards," says Dr. Marisa Weiss, a leading breast oncologist and founder and president of Breastcancer.org.

19 Nov 2009

Precision BioSciences: EPO revokes Cellectis’ European Patent No. EP 1485475

Yesterday, the European Patent Office (EPO) revoked previously granted claims of Cellectis’ European Patent No. EP 1485475 during an oral hearing in an opposition proceeding initiated by Precision BioSciences. As a result of the opposition, Cellectis’ previously granted claims to single-chain meganucleases, including those derived from I-CreI, were revoked in their entirety. Claims to hybrid meganucleases were cancelled or severely restricted.

19 Nov 2009

eHealthInsurance releases six-point checklist to get the most out of Medicare coverage

eHealthInsurance, the leading online source of health insurance for individuals, families, and small businesses, that now offers a new online Medicare resource, www.eHealthMedicare.com, today released a six-point checklist to help Medicare recipients make informed decisions about their Medicare options.

19 Nov 2009

Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects

Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their performance enhancing qualities.

19 Nov 2009

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved. Although historically it was considered that liver metastases meant a very poor prognosis, today, due to improved systemic therapy, many patients will be candidates for local hepatic treatments such as surgery or less aggressive radiofrequency ablation.

19 Nov 2009

Air pollution: An important health concern for people living near regional airports

Scientists are reporting evidence that air pollution - a well-recognized problem at major airports - may pose an important but largely overlooked health concern for people living near smaller regional airports.

19 Nov 2009

NHS to use IOCOM technology for its East of England telemedicine project

IOCOM, a leading software provider for enterprise-class video conferencing capabilities, today announced that the UK’s National Health Service (NHS) is using IOCOM technology for its East of England telemedicine project.

19 Nov 2009

AFFiRiS to commence Phase II trial of its Alzheimer's vaccine candidate

AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.

19 Nov 2009

Expansion of Excelyte manufacturing plant completed at Midland

Integrated Environmental Technologies, Ltd. announces that Benchmark Performance Group, Inc., its exclusive worldwide distributor serving the oil and gas industry, has completed the expansion of its Excelyte® manufacturing plant at its Midland, Texas facility.

19 Nov 2009

RBM and Covance sign biomarker alliance and services agreement

Rules-Based Medicine, Inc. (RBM) today announced it has entered into a biomarker alliance and services agreement with Covance Inc. that will provide biotechnology and pharmaceutical companies with a powerful combination of biomarker technologies and services for use in drug development. Under terms of the agreement, Covance will use RBM as its exclusive third-party provider of multiplexed protein biomarker testing services, and RBM shall use Covance as its exclusive referral source for laboratory testing services.

19 Nov 2009

UNGASS monitoring system provides the overall progress in the global response to HIV

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic. An update on the development of the UN General Assembly Special Session on HIV/AIDS (UNGASS) global reporting system appears in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes.

19 Nov 2009

Six new degree programs to be offered by High-Tech Institute in Minneapolis

High-Tech Institute in Minneapolis will begin offering six new degree programs, with a class start set for January 11, 2010 for all programs. The school is located at 5100 Gamble Drive, Suite 200 in St. Louis Park, Minn.

19 Nov 2009

Medical News

NanoString Technologies to investigate molecular networks with the Broad Institute of MIT and Harvard

Global 'phase down' of dental mercury use finds support

Molina Healthcare's Medicaid plans included in 'America’s Best Health Insurance Plans'

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

New online tool launched to encourage donations and fight global hunger

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

NeuroRehabilitation: A one-stop resource for persons with neurodisabilities

New study sheds light on potassium pore dynamics and serves as an important foundation for research

Breastcancer.org opposes proposed new guidelines for mammograms

Precision BioSciences: EPO revokes Cellectis’ European Patent No. EP 1485475

eHealthInsurance releases six-point checklist to get the most out of Medicare coverage

Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects

Report on unexplained liver haemorrhage after metastasis radiofrequency ablation published

Air pollution: An important health concern for people living near regional airports

NHS to use IOCOM technology for its East of England telemedicine project

AFFiRiS to commence Phase II trial of its Alzheimer's vaccine candidate

Expansion of Excelyte manufacturing plant completed at Midland

RBM and Covance sign biomarker alliance and services agreement

UNGASS monitoring system provides the overall progress in the global response to HIV

Six new degree programs to be offered by High-Tech Institute in Minneapolis

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News